Pharma Companies Suspecting Clinical Trial Fraud Should Move Quickly, Quietly

 
• By Sue Sutter
  
Looking for fraud
Clinical data anomalies can help sponsors and regulators find fraud. (Shutterstock)

More from Regional Comparisons

More from R&D